Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 240

Similar articles for PubMed (Select 11106135)

1.

Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment.

Walker JR, Van Ameringen MA, Swinson R, Bowen RC, Chokka PR, Goldner E, Johnston DC, Lavallie YJ, Nandy S, Pecknold JC, Hadrava V, Lane RM.

J Clin Psychopharmacol. 2000 Dec;20(6):636-44.

PMID:
11106135
2.

Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.

Van Ameringen MA, Lane RM, Walker JR, Bowen RC, Chokka PR, Goldner EM, Johnston DG, Lavallee YJ, Nandy S, Pecknold JC, Hadrava V, Swinson RP.

Am J Psychiatry. 2001 Feb;158(2):275-81.

PMID:
11156811
3.

Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study.

Liebowitz MR, DeMartinis NA, Weihs K, Londborg PD, Smith WT, Chung H, Fayyad R, Clary CM.

J Clin Psychiatry. 2003 Jul;64(7):785-92.

PMID:
12934979
4.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
5.

Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.

Liebowitz MR, Gelenberg AJ, Munjack D.

Arch Gen Psychiatry. 2005 Feb;62(2):190-8.

PMID:
15699296
6.

A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder.

Montgomery SA, Nil R, Dürr-Pal N, Loft H, Boulenger JP.

J Clin Psychiatry. 2005 Oct;66(10):1270-8.

PMID:
16259540
7.
8.

A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder.

Liebowitz MR, Mangano RM, Bradwejn J, Asnis G; SAD Study Group.

J Clin Psychiatry. 2005 Feb;66(2):238-47.

PMID:
15705011
9.

Efficacy of paroxetine for relapse prevention in social anxiety disorder: a 24-week study.

Stein DJ, Versiani M, Hair T, Kumar R.

Arch Gen Psychiatry. 2002 Dec;59(12):1111-8.

PMID:
12470127
10.

Predictors of response in generalized social phobia: effect of age of onset.

Van Ameringen M, Oakman J, Mancini C, Pipe B, Chung H.

J Clin Psychopharmacol. 2004 Feb;24(1):42-8.

PMID:
14709946
11.

Sertraline for social phobia: a double-blind, placebo-controlled crossover study.

Katzelnick DJ, Kobak KA, Greist JH, Jefferson JW, Mantle JM, Serlin RC.

Am J Psychiatry. 1995 Sep;152(9):1368-71.

PMID:
7653696
12.
13.

Efficacy of sertraline in a 12-week trial for generalized anxiety disorder.

Allgulander C, Dahl AA, Austin C, Morris PL, Sogaard JA, Fayyad R, Kutcher SP, Clary CM.

Am J Psychiatry. 2004 Sep;161(9):1642-9.

PMID:
15337655
14.

Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment.

Londborg PD, Hegel MT, Goldstein S, Goldstein D, Himmelhoch JM, Maddock R, Patterson WM, Rausch J, Farfel GM.

J Clin Psychiatry. 2001 May;62(5):325-31.

PMID:
11411812
15.

An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression.

Schneider LS, Nelson JC, Clary CM, Newhouse P, Krishnan KR, Shiovitz T, Weihs K; Sertraline Elderly Depression Study Group.

Am J Psychiatry. 2003 Jul;160(7):1277-85.

PMID:
12832242
16.

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.

Davidson J, Pearlstein T, Londborg P, Brady KT, Rothbaum B, Bell J, Maddock R, Hegel MT, Farfel G.

Am J Psychiatry. 2001 Dec;158(12):1974-81.

PMID:
11729012
17.

Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.

Stein MB, Fyer AJ, Davidson JR, Pollack MH, Wiita B.

Am J Psychiatry. 1999 May;156(5):756-60.

PMID:
10327910
18.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
19.

A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia.

Mulholland C, Lynch G, King DJ, Cooper SJ.

J Psychopharmacol. 2003 Mar;17(1):107-12.

PMID:
12680747
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk